Last update:

HIV & AIDS news

HIV & AIDS

For many HIV+ women, daily survival takes precedence over viral suppression

According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that ...

HIV & AIDS

Number of HIV cases continue to decline in New Zealand

For the second year in a row there has been a reduction in the number of confirmed cases of HIV in New Zealand.

HIV & AIDS

HIV outbreak sparks panic in southern Pakistan

Parents nervously watch as their children wait to be tested for HIV in a village in southern Pakistan, where hundreds of people have been allegedly infected by a doctor using a contaminated syringe.

HIV & AIDS

Once-per-month HIV drugs on the horizon

An HIV diagnosis was once a death sentence, but now people who receive treatment survive for decades with the disease. Keeping the virus at bay usually requires taking a pill every day, which aside from being inconvenient ...

HIV & AIDS

CDC: HIV racial disparity measure decreased from 2010 to 2016

(HealthDay)—If the incidence rates were the same for black women as for white women, an estimated 93 percent of incident HIV infections among black women would not have occurred in 2016, according to research published ...

HIV & AIDS

New HIV vaccine strategy 'pumps' the immune system

A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical model. Scientists at the La Jolla Institute for Immunology (LJI) have discovered that delivering an HIV vaccine in small ...

HIV & AIDS

AIDS in America—Back in the headlines at long last

President Trump's recent call to end the HIV epidemic in the United States has turned attention to a domestic public health crisis that has been absent from the headlines for quite some time.

HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

HIV & AIDS

Gene-editing technique opens door for HIV vaccine

The human body cannot naturally defend itself against HIV—not usually, at least. But in very rare cases, infected individuals generate broadly neutralizing antibodies, or bNAbs, that fight the virus. Now, Rockefeller scientists ...

HIV & AIDS

In rare cases, immune system fails despite HIV suppression

Antiretroviral therapy (ART) is usually very effective at suppressing HIV in the body, allowing a person's immune system to recover by preventing the virus from destroying CD4+ T cells. Scientists have now identified a rare, ...